Adjuvant Pembrolizumab Prolongs DFS Among Patients with High-Risk Muscle Invasive Urothelial Carcinoma - report from ESMO2024

from Medical Digest & Congress Report · host Medical Congress News

Professor Petros Grivas shares his insights on the AMBASSADOR study. Video: https://medicaldigest.org/scientific-contents/interview:adjuvant-pembrolizumab-prolongs-dfs-among-patients-high-risk-muscle-invasive-urothelial-carcinoma

Episode metadata supplied by the publisher feed · Published Oct 24, 2024

Embed this episode

Attribution link and audio player

Ready to play

Adjuvant Pembrolizumab Prolongs DFS Among Patients with High-Risk Muscle Invasive Urothelial Carcinoma - report from ESMO2024

0:00 4:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 4 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 24, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!